Evidence map›Paper›PMID 11160154›Full record

ArticleThe Journal of clinical investigation2001

Fibroblast-like synoviocytes support B-cell pseudoemperipolesis via a stromal cell-derived factor-1- and CD106 (VCAM-1)-dependent mechanism.

J A Burger, N J Zvaifler, N Tsukada, G S Firestein, T J Kipps

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of clinical investigation, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 178 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Lymphoid stroma in all its states.Frontiers in immunology · 2025
    Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

J A BurgerDepartment of Medicine, Division of Hematology/Oncology, University of California-San Diego, 9500 Gilman Drive, La Jolla, California 92093-0663, USA.
N J Zvaifler
N Tsukada
G S Firestein
T J Kipps
University of California, San Diego · US

Funding

SYNOVIUM AS AN IMMUNE UNDERPRIVILEGED SITEP50AR044850 · NIAMS · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI FIRESTEIN, GARY STEVEN · 1998 to 2002
$3.3M
SYNOVIAL DYSFUNCTION DUE TO P53 ABNORMALITIES IN RAR01AR045347 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY STEVEN · 1997 to 2006
$2.2M
NIAMS NIH HHS AR44850NIAMS NIH HHS AR45347NIAMS NIH HHS R01 AR045347
6 · The paper itself

Abstract

B-cell accumulation and formation of ectopic germinal centers are characteristic changes in the diseased joints of patients with rheumatoid arthritis (RA). Earlier studies suggested that interactions between B lymphocytes and specialized synovial "nurse-like" cells peculiar to the RA synovium may be responsible for the homing and sustained survival of B cells in the synovium. However, in this study, we found that B cells spontaneously migrate beneath ordinary fibroblast-like synoviocytes (FLSs) and then experience prolonged survival. FLSs isolated from joints of patients with osteoarthritis also supported this activity, termed B-cell pseudoemperipolesis. We found that FLSs constitutively expressed the chemokine stromal cell-derived factor-1 (SDF-1), and that pertussis toxin or antibodies to the SDF-1 receptor (CXCR4) could inhibit B-cell pseudoemperipolesis. However, expression of SDF-1 is not sufficient, as dermal fibroblasts also expressed this chemokine but were unable to support B-cell pseudoemperipolesis unless previously stimulated with IL-4 to express CD106 (VCAM-1), a ligand for the alpha(4)beta(1) integrin, very-late-antigen-4 (VLA-4 or CD49d). Furthermore, mAb's specific for CD49d and CD106, or the synthetic CS1 fibronectin peptide, could inhibit B-cell pseudoemperipolesis. We conclude that ordinary FLSs can support B-cell pseudoemperipolesis via a mechanism dependent upon fibroblast expression of SDF-1 and CD106.

Indexed as

Arthritis, RheumatoidB-LymphocytesCell LineCell Membrane PermeabilityChemokine CXCL12Chemokines, CXCFibroblastsFlow CytometryFluorescent Antibody TechniqueHumansIntegrin alpha4beta1IntegrinsInterleukin-4Membrane PotentialsReceptors, Lymphocyte HomingSkinChemokine CXCL12Chemokines, CXCCXCL12 protein, humanIntegrin alpha4beta1IntegrinsInterleukin-4Receptors, Lymphocyte HomingVascular Cell Adhesion Molecule-1

Identifiers

PMID11160154
PMCPMC199194
OpenAlexW2117716762

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.